Ironwood Pharmaceuticals, Inc. - (IRWD)
Last updated: 2026-10-20 11:46:41. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Ironwood Pharmaceuticals, Inc. - (IRWD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.54, with a market capitalization of $578.34M and a P/E ratio of 4.53. Over the past 52 weeks, its price has ranged from $1.44 to $5.78. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$578.34M | |
$3.54 | |
$21.20 | |
$0.53 | |
$3.56 | |
918.00 | |
2.01M | |
4.53 | |
$5.78 | |
$1.44 | |
-- | |
-- |
Ironwood Pharmaceuticals, Inc. - (IRWD) Pre-Market Stock Price
Ironwood Pharmaceuticals, Inc. - (IRWD) is trading at $3.54 in pre-market trading as of 2026-10-20 11:10:00, down 0.56% ($0.02) from the previous close of $3.56
Pre-market trading shows how investors are pricing IRWD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Ironwood Pharmaceuticals, Inc. - (IRWD) 7-Day Stock Price Change
Over the past seven days, Ironwood Pharmaceuticals, Inc. - (IRWD) moved from $3.82 to $3.54, representing a decline of 7.33% ($0.28).
The stock traded between $3.48 and $3.95 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.76 million shares, down versus the previous seven-day period, indicating lower trading activity.
IRWD 52-Week Price Position
Position in Range: 48.4%
IRWD is currently trading at $3.54, placing it 48.4% of the way from its 52-week low of $1.44 to its 52-week high of $5.78. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Ironwood Pharmaceuticals, Inc. - (IRWD)?
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Ironwood Pharmaceuticals, Inc. - Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 100 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Ironwood Pharmaceuticals, Inc. - (IRWD) Stock on MEXC
Eligible investors can buy real shares of Ironwood Pharmaceuticals, Inc. - (IRWD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Ironwood Pharmaceuticals, Inc. - (IRWD) stock price today?
2.Is IRWD stock going up or down today?
3.What is IRWD pre-market price?
4.What is IRWD after-hours price?
5.Is IRWD stock trading now?
6.Where does IRWD sit relative to its 52-week high and low?
7.What sector is Ironwood Pharmaceuticals, Inc. - in?
8.What is Ironwood Pharmaceuticals, Inc. -'s market capitalization and where is it listed?
9.How is IRWD valued in terms of P/E ratio and EPS?
10.Does Ironwood Pharmaceuticals, Inc. - pay a dividend?
Explore More US Stocks
Search Stocks
IRWD Stock Calculator
Estimate the value between IRWD shares and USD.
IRWD Shares to USD
1.00 IRWD shares = 3.54 USD
Calculations are estimates based on the latest available price and are for reference only.


